Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremBIRMF 86 Earnings per Share (Diluted) is $0.24 as of Jun. 2026. GuruFocus rates BIRMF with a GF Score™ of 86/100 and a GF Value™ of $2.45 (Fairly Valued). The stock has 3 warning signs investors should review. Among 2,421 Industrial Products companies, Biorem ranks better than 86.82% on this metric.
Biorem's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.09.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.27.
Biorem's EPS without NRI for the
three
months ended in Jun. 2026 was $0.07.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $0.24.
During the past 12 months, Biorem's average EPS without NRIGrowth Rate was 96.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 43.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 44.60% per year.
During the past 13 years, Biorem's highest 3-Year average EPS without NRI Growth Rate was 54.40% per year. The lowest was -102.10% per year. And the median was 10.00% per year.
Biorem (OTCPK:BIRMF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Biorem Earnings per Share (Diluted) Related Terms
Biorem Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Biorem's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIRMF vs VLTO, ZWS, CECO: Earnings per Share (Diluted) Comparison
For the Pollution & Treatment Controls subindustry, Biorem's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biorem PE Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Biorem's PE Ratio distribution charts can be found below:
* The bar in red indicates where Biorem's PE Ratio falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Biorem's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.24 mean?
Biorem (BIRMF) has a Earnings per Share (Diluted) of $0.24 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Biorem and its competitors. According to the industry distribution chart, Biorem ranks #319 out of 2421 companies in the Industrial Products industry, placing it in the top 13.2%.
Is Biorem's Earnings per Share (Diluted) too high?
Biorem's current Earnings per Share (Diluted) is $0.24. The Industrial Products industry median Earnings per Share (Diluted) is 3.60. Biorem's value of $0.24 is 93.3% below this industry median. Based on the distribution chart, Biorem ranks #319 out of 2421 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Biorem has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Earnings per Share (Diluted) compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #319 out of 2421 companies for Earnings per Share (Diluted). This places Biorem in the top 13% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 3.60. Biorem's value of $0.24 is 93.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for an Industrial Products company?
The median Earnings per Share (Diluted) among Industrial Products companies is 3.60, based on 2,421 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biorem's current Earnings per Share (Diluted) of $0.24 is 93.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Biorem and its competitors. For the Industrial Products industry, the median Earnings per Share (Diluted) is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current Earnings per Share (Diluted) is $0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Fairly Valued. The stock's GF Value™ is $2.45, compared to a current price of $2.57 — trading 4.9% above its estimated fair value. The current Earnings per Share (Diluted) is $0.24 and 93.3% below the Industrial Products industry median of 3.60. Biorem's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Biorem (BIRMF), the current Earnings per Share (Diluted) is $0.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (BIRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of $2.57 is trading 4.9% above its estimated GF Value™ of $2.45.
GuruFocus considers Biorem to be Fairly Valued.
Key valuation signals for BIRMF:
Earnings per Share (Diluted): $0.24
GF Value™: $2.45 vs. price of $2.57 (4.9% above fair value)
Industry Position: 93.3% below the Industrial Products median (#319 of 2421)
No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
86GF Score
Get the complete analysis for BIRMF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIRMF has been successfully added to your 
